IRIS Accounts Production v24.3.0.553 04163487 Board of Directors 1.5.23 30.4.24 30.4.24 false true false false true false Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh041634872023-04-30041634872024-04-30041634872023-05-012024-04-30041634872022-04-30041634872022-05-012023-04-30041634872023-04-3004163487ns15:EnglandWales2023-05-012024-04-3004163487ns14:PoundSterling2023-05-012024-04-3004163487ns10:Director12023-05-012024-04-3004163487ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3004163487ns10:SmallEntities2023-05-012024-04-3004163487ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3004163487ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3004163487ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3004163487ns10:FullAccounts2023-05-012024-04-3004163487ns10:OrdinaryShareClass12023-05-012024-04-3004163487ns10:Director22023-05-012024-04-3004163487ns10:CompanySecretary12023-05-012024-04-3004163487ns10:RegisteredOffice2023-05-012024-04-3004163487ns5:CurrentFinancialInstruments2024-04-3004163487ns5:CurrentFinancialInstruments2023-04-3004163487ns5:ShareCapital2024-04-3004163487ns5:ShareCapital2023-04-3004163487ns5:RetainedEarningsAccumulatedLosses2024-04-3004163487ns5:RetainedEarningsAccumulatedLosses2023-04-3004163487ns5:PlantMachinery2023-05-012024-04-3004163487ns5:LandBuildings2023-04-3004163487ns5:PlantMachinery2023-04-3004163487ns5:LandBuildings2023-05-012024-04-3004163487ns5:LandBuildings2024-04-3004163487ns5:PlantMachinery2024-04-3004163487ns5:LandBuildings2023-04-3004163487ns5:PlantMachinery2023-04-3004163487ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3004163487ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-3004163487ns10:OrdinaryShareClass12024-04-30
REGISTERED NUMBER: 04163487 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30TH APRIL 2024

FOR

HODGSON PHARMACY LIMITED

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH APRIL 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


HODGSON PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30TH APRIL 2024







DIRECTORS: Mr D C Patel
Mr A D Patel



SECRETARY: Mr D C Patel



REGISTERED OFFICE: 59 Station Road
Longfield
Kent
DA3 7QA



REGISTERED NUMBER: 04163487 (England and Wales)



BANKERS: National Westminster Bank plc
12 High Street
Dartford
Kent
DA1 1DD

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

BALANCE SHEET
30TH APRIL 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 127,288 117,729

CURRENT ASSETS
Stocks 83,708 79,577
Debtors 5 35,970 43,780
Cash at bank and in hand 324,584 227,454
444,262 350,811
CREDITORS
Amounts falling due within one year 6 324,128 234,600
NET CURRENT ASSETS 120,134 116,211
TOTAL ASSETS LESS CURRENT
LIABILITIES

247,422

233,940

PROVISIONS FOR LIABILITIES 47,000 47,000
NET ASSETS 200,422 186,940

CAPITAL AND RESERVES
Called up share capital 7 20,000 20,000
Retained earnings 180,422 166,940
SHAREHOLDERS' FUNDS 200,422 186,940

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18th November 2024 and were signed on its behalf by:





Mr D C Patel - Director


HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30TH APRIL 2024


1. STATUTORY INFORMATION

Hodgson Pharmacy Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 04163487 and registered office address is 59 Station Road, Longfield, Kent, DA3 7QA.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2023 - 9 ) .

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1st May 2023 29,286 485,063 514,349
Additions - 35,220 35,220
At 30th April 2024 29,286 520,283 549,569
DEPRECIATION
At 1st May 2023 23,616 373,004 396,620
Charge for year 851 24,810 25,661
At 30th April 2024 24,467 397,814 422,281
NET BOOK VALUE
At 30th April 2024 4,819 122,469 127,288
At 30th April 2023 5,670 112,059 117,729

HODGSON PHARMACY LIMITED (REGISTERED NUMBER: 04163487)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30TH APRIL 2024


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 8,052 8,559
Other debtors 27,918 35,221
35,970 43,780

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 228,092 168,350
Taxation and social security 30,159 2,338
Other creditors 65,877 63,912
324,128 234,600

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
20,000 Ordinary shares £1 20,000 20,000

8. RELATED PARTY DISCLOSURES

The company paid £12,000 (2023: £12,000) as rent to Mr D.C. Patel. An amount of £41,695 (2023: £24,318) was due to Mr D C Patel at the year end.

9. ULTIMATE CONTROLLING PARTY

The company was under the control of the director and majority shareholder, Mr D.C. Patel throughout the current year and previous period.